Global Cell Therapy And Tissue Engineering Market Size By Material (Biologically Derived, Synthetic), By Type (Cell Therapy, Tissue Engineering), By Application (Genetic Diseases, Tissue Malignancy), By Geographic Scope And Forecast
Report ID: 12301|No. of Pages: 202
Global Cell Therapy And Tissue Engineering Market Size By Material (Biologically Derived, Synthetic), By Type (Cell Therapy, Tissue Engineering), By Application (Genetic Diseases, Tissue Malignancy), By Geographic Scope And Forecast
Cell Therapy And Tissue Engineering Market Size And Forecast
Cell Therapy And Tissue Engineering Market size was valued at USD 32.3 Billion in 2024 and is projected to reach USD 95.4 Billion by 2031, growing at a CAGR of 31.42% from 2024 to 2031.
Since the term “tissue engineering” was invented in 1993, the sectors of tissue engineering, cell therapy, and regenerative medicine have progressed from benchtop ideas to commercial products that are broadly used in clinics. The ability of tissue engineering processes to treat irreversible tissue damage has boosted market growth. Furthermore, an increase in demand for regenerative medicine and tissue engineering processes to cure injured tissue augments this growth. The Global Cell Therapy And Tissue Engineering Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Cell Therapy And Tissue Engineering Market Definition
Cell therapy is the use of living cells to treat or potentially cure human illness or condition. Tissue engineering is a medical field that focuses on restoring, sustaining, significantly improving, or substituting damaged tissues and organs by combining scaffolds, cells, and bioactive molecules. The National Center for Biotechnology Information defines tissue engineering broadly as the integration of engineering and biology to progress the reconstruction or improve the performance of tissue function. For regenerative purposes, artificial organs, biomaterials, and cell therapies that use autologous or donor cells have been used.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=12301
Global Cell Therapy And Tissue Engineering Market Overview
The Cell Therapy And Tissue Engineering Market is expected to expand rapidly due to rising rates of chronic diseases, traffic accidents, and severe injuries, technical advances in 3D tissue engineering, and continuing tissue regeneration research. The increasing prevalence of chronic diseases, traffic accidents, and trauma injuries has been discovered to be making a contribution to the expansion in the advancement of tissue engineering remedies. The number of individuals who need bone implants is growing due to an increase in chronic disease cases, trauma cases, and an increase in average life span.
Furthermore, there is a demand for relatively inexpensive and readily available skin-replacement products, which has prompted many research groups around the world to focus on developing biomaterials for skin substitution. The engineered tissues not only close wounds but also stimulate dermal regeneration, offering a major benefit in human wound healing. The procedures are extremely expensive, posing the biggest obstacle to the global market.
Global Cell Therapy And Tissue Engineering Market: Segmentation Analysis
The Global Cell Therapy And Tissue Engineering Market is segmented on the basis of Material, Type, Application, And Geography.
Cell Therapy And Tissue Engineering Market, By Material
• Biologically Derived
• Synthetic
• Others
Based on Material, The market is segmented into Biologically Derived, Synthetic, and Others. For its efficiency over other natural origin derived materials, the Synthetic materials segment is projected to expand significantly. Synthetic materials are chosen over natural materials because they produce better results. Due to characteristics like biocompatibility, biodegradability, non-toxicity, good cell recognition properties, and ease of functionalization, biologically derived materials are aiding the Cell Therapy And Tissue Engineering Market growth.
Cell Therapy And Tissue Engineering Market, By Type
• Cell Therapy
• Tissue Engineering
• Others
Based on Type, The market is segmented into Cell Therapy, Tissue Engineering, and Others. The Cell Therapy segment has been dominating the market in the past, Owing to the expanding pipeline for therapies. The treatment using the Cell Therapy of the immune system and blood disorders for cancer patients has driven the growth of this segment. However, the tissue engineering segment is expected to witness significant growth during the forecast period. The innovative 3D-designed nano-fibers have proved to be an alternative to repair and regenerate damaged neurons. Such techniques have boosted the growth of tissue engineering products.
Cell Therapy And Tissue Engineering Market, By Application
• Genetic Diseases
• Tissue Malignancy
• Cell Defects
• Neurodegenerative Disease
• Others
Based on Application, The market is segmented into Genetic Diseases, Tissue Malignancy, Cell Defects, Neurodegenerative Disease, and Others. Due to the widespread use of stem cell therapies in organ transplants for the treatment of immune systems and blood abnormalities in cancer patients, the Cell Defects segment is projected to expand profitably during the forecast period. Furthermore, advances in technology and the use of advanced equipment have resulted in an increase in the application areas of neurodegenerative diseases. During the forecast period, this is expected to drive demand for this segment.
Cell Therapy And Tissue Engineering Market, By Geography
• North America
• Europe
• Asia Pacific
• Rest of the world
On the basis of Geography, The Global Cell Therapy And Tissue Engineering Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The presence of cutting-edge universities and research centers for Stem Cell Biology in the United States of America is a major factor driving the growth of cell therapy and tissue engineering in North America. Furthermore, significant funding from federal agencies for the growth of this industry is propelling the market. Because of the region’s growing awareness of tissue-engineered products, rising demand for innovative healthcare services in emerging markets, developing R&D sector, and increased presence of key players, Asia-Pacific introduces lucrative opportunities for players operating in the Cell Therapy And Tissue Engineering Market. Furthermore, the growing focus on regenerative medicine and the development of healthcare infrastructure has resulted in rapid market development.
Key players
The “Global Cell Therapy And Tissue Engineering Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as BioCardia Inc., Betalin Therapeutics Ltd., MEDIPOST Co., Ltd, MaxCyte Inc., BioReliance Corporation, AbbVie Inc., Integra Lifesciences, Becton, Dickinson, and Company, Zimmer Biomet, C. R. Bard, Organogenesis, Biotime Inc., B. Braun Melsungen AG, Bio Tissue Technologies, Osiris Therapeutics.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Key Developments
• April 2022 – Bonus BioGroup, a Haifa-based biotech company, recently finished a preclinical trial regarding the efficacy of its drug MesenCure, which is being formed for the treatment of serious COVID patients, in limiting life-threatening inflammatory overreaction seen in patients with cytokine release syndrome.
• April 2022 – Satellite Bio raises $110 million to fund the development of implantable tissue therapies.
• April 2022 – Essent biologics introduces human mesenchymal stromal cells derived from Wharton’s jelly to advance cell therapy research.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2021-2031 |
| Base Year | 2024 |
| Forecast Period | 2024-2031 |
| Historical Period | 2021-2023 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | BioCardia Inc., Betalin Therapeutics Ltd., MEDIPOST Co., Ltd, MaxCyte Inc., BioReliance Corporation, AbbVie Inc., Integra Lifesciences. |
| Segments Covered | By Material, By Type, By Application, And By Geography. |
| Customization scope | Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF GLOBAL CELL THERAPY AND TISSUE ENGINEERING MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL CELL THERAPY AND TISSUE ENGINEERING MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 GLOBAL CELL THERAPY AND TISSUE ENGINEERING MARKET, BY MATERIAL
5.1 Overview
5.2 Biologically Derived
5.3 Synthetic
5.4 Others
6 GLOBAL CELL THERAPY AND TISSUE ENGINEERING MARKET, BY TYPE
6.1 Overview
6.2 Tissue Engineering
6.3 Cell Therapy
6.4 Others
7 GLOBAL CELL THERAPY AND TISSUE ENGINEERING MARKET, BY APPLICATION
7.1 Overview
7.2 Genetic Diseases
7.3 Tissue Malignancy
7.4 Cell Defects
7.5 Neurodegenerative Disease
7.6 Others
8 GLOBAL CELL THERAPY AND TISSUE ENGINEERING MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Rest of the World
8.5.1 Latin America
8.5.2 Middle East and Africa
9 GLOBAL CELL THERAPY AND TISSUE ENGINEERING MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies
10 COMPANY PROFILES
10.1 Integra Lifesciences (US)
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 AbbVie Inc. (US)
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Becton, Dickinson, and Company (US)
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 C. R. Bard (US)
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Organogenesis (US)
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Biotime Inc. (US)
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 B. Braun Melsungen AG (Germany)
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 BioCardia Inc. (US)
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Zimmer Biomet (US)
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Osiris Therapeutics (US)
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
11 KEY DEVELOPMENTS
11.1 Product Launches/Developments
11.2 Mergers and Acquisitions
11.3 Business Expansions
11.4 Partnerships and Collaborations
12 Appendix
12.1 Related Research
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
